Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Chr Hansen Holding A/S    CHRH   DK0060227585

Delayed Quote. Delayed BATS EUROPE - 04/24 04:54:10 pm
339.0000 DKK   +1.16%
04/11 CHR HANSEN A/S : . Hansen accelerates efforts within human microbiom..
01/21 CHR HANSEN A/S : Positive start to the year
2014 CHR HANSEN A/S : Is carmine natural?
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Chr. Hansen Holding : Announcements from Financière Star 1 S.A. and Novo A/S in accordance with Section 29 of the Danish Securities Trading Act

03/29/2012 | 07:14am US/Eastern

Hoersholm, 2012-03-29 11:38 CEST (GLOBE NEWSWIRE) --  

Company announcement no.12/2012

Today Chr. Hansen Holding A/S has received major shareholder announcements from Financière Star 1 S.A. and Novo A/S.

According to the announcement from Financière Star 1 S.A., Financière Star 1 S.A. today has sold 35,419,331 shares in Chr. Hansen Holding A/S thus reducing its holdings of shares in Chr. Hansen Holding A/S to 129,442 shares (corresponding to 0.09% of the share capital and voting rights).

According to the announcement from Novo A/S, Novo A/S today has acquired 35,419,331 Chr. Hansen Holding A/S shares and now holds 35,419,331 shares in Chr. Hansen Holding A/S (corresponding to 25.66% of the share capital and voting rights).

The above changes are due to the completion of the share purchase agreement between Financière Star 1 S.A. and Novo A/S announced in company announcement no. 02/2012 of 11 January 2012.

For further information, please contact:

Anders Mohr Christensen, Head of Investor Relations

Tel: +45 4574 7618

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products are centered around cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2010/11 financial year was EUR 636 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,300 dedicated employees in over 30 countries. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.www.chr-hansen.com.

distributed by

This press release was issued by Chr. Hansen Holding A/S and was initially posted at http://investor.chr-hansen.com/releasedetail.cfm?ReleaseID=660271 . It was distributed, unedited and unaltered, by noodls on 2012-03-29 13:06:51 PM. The issuer is solely responsible for the accuracy of the information contained therein.

React to this article
Latest news on CHR HANSEN HOLDING A/S
04/14 CHR HANSEN A/S : Major shareholder announcement from APG Asset Management N.V.
04/11 CHR HANSEN A/S : . Hansen accelerates efforts within human microbiome
04/09 CHR HANSEN A/S : Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0..
04/08 CHR HANSEN A/S : Patent Application Titled "Use of Lactic Acid Bacteria for Prep..
04/08 CHR HANSEN A/S : Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0..
04/01 CHR HANSEN A/S : Patent Application Titled "Bioprotection Using Lactobacillus Rh..
03/11 CHR HANSEN A/S : Trademark Application for "GR-1" Filed by Chr. Hansen
02/04 CHR HANSEN A/S : . Hansen's Trademark Application for "MEDIPHARM" Filed
01/21 CHR HANSEN A/S : Positive start to the year
01/08 CHR HANSEN A/S : Patent Application Titled "Bile Resistant Bacillus Composition"..
Advertisement
Chart
Duration : Period :
Chr Hansen Holding A/S Technical Analysis Chart | CHRH | DK0060227585 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF